top of page

Abstract submission closes
1 Oct 2024,
23:59 GMT

30th MCLOSA Annual Meeting


MCLOSA welcomes abstracts from trainee, SAS and consultant grade doctors as well as optometrists working in the area of ocular surface disease.
Only Clinical Research Fellows, Ophthalmology Trainees or Trainee level Research Optometrists working in the area of ocular surface disease  will be eligible to be considered for the Bron Award of £500.

Bron Award
Open to  
Clinical Research Fellows and Ophthalmology or Optometry  Trainees

PRIZE = £500

Abstract structure:

  • Abstracts should be submitted as structured abstracts, to CLAE style.

  • As a UK meeting please use UK spelling and terminology.

  • The full names of co-authors should be included (first then surname).

  • Guide word count - 250 words.

Entry Requirements and Submission:

  • All abstract submissions must be sent via the electronic form by 9 October 2023, midnight.

  • All abstracts will be marked by a panel of expert judges and the successful abstracts will then be shortlisted for oral presentation or Poster ONLY.  

  • A Clinical Research Fellow or Ophthalmology Trainee applicant MUST be the first author should they wish to be considered for the Bron Award.


  • Abstract submitters will be notified by the 21st October of the result of the marking.

  • All successful abstract presenters (oral or poster-only) will be required to register for the 2023 MCLOSA meeting.


Bron Award objective:

To determine the best piece of individually generated UK clinical/basic sciences research by a Clinical Research Fellow or Ophthalmology Trainee (ST4 onwards) working in the area of ocular surface disease. The research must be new and original, i.e. not presented in other meetings or published/submitted for publication in any journal.

Ethos - "Petri dish to patient":

To reward research that focus on the benefits to patients and which seeks to challenge current medical practice.

In addition, the reward will focus on innovative research into areas of unmet medical need or areas where current treatment outcomes are considered sub-optimal or non cost effective.

The Bron Award:

Will be presented at the 2024 MCLOSA Meeting along with an award for £500.

Shortlisting and presentation:

A shortlist of three finalists will be expected to present their respective research as an oral presentation at the meeting. The judges will make the final decision regarding the Bron Award on the day.

Judging Panel:

The judging panel will consist of an esteemed panel of Ophthalmologists with special interest in Ocular Surface.


bottom of page